Arrayjet
Publications

Relating to Diagnostics

Publication

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

Albert Einstein College of Medicine
2023

Publication

Prediction of short-term mortality in elderly patients with sepsis using immunoglobulin G2: An observational study

Capital Medical University, Beijing
2023

Publication

Protein microarray allergen profiling in bronchoalveolar lavage fluid and serum of horses with asthma

University of Bern and Nottingham Trent University
2023

Publication

Polarization and β-Glucan Reprogram Immunomodulatory Metabolism in Human Macrophages and Ex Vivo in Human Lung Cancer Tissues

University of Kentucky
2023

Publication

Detection of breast cancer-related point-mutations using screen-printed and gold-plated electrochemical sensor arrays suitable for point-of-care applications

AIT Austrian Institute of Technology
2022

Publication

SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling

Shanghai Jiao Tong University
2022

Publication

Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients

Huazhong University of Science and Technology and Shanghai Jiao Tong University
2022

Publication

Component‐resolved microarray analysis of IgE sensitization profiles to Culicoides recombinant allergens in horses with insect bite hypersensitivity

University of Bern
2021

Publication

First clinical expression of equine insect bite hypersensitivity is associated with co-sensitization to multiple Culicoides allergens

University of Bern and Nottingham Trent University
2021

Keep up to date with our news...

Join our mailing list

Speak to an expert

Get advice on the best solution for your application

Arrange a consultation with one of our team to find out more about Arrayjet, our ground-breaking tech and World-class services.  You can also arrange to see our instruments for yourselves at our headquarters in Edinburgh, or visit one of our global reference sites.